Japan In-Vitro Diagnostics (IVD) Market Set to Reach US$ 3.24 Billion by 2028
According to Renub Research, the Japan In-Vitro Diagnostics (IVD) market is projected to grow to US$ 3.24 billion by 2028. This growth is driven by various factors, including the rising demand for molecular diagnostic tests and a significant shift towards automation and digitalization in healthcare.
Key Insights from Renub Research
Renub Research has published an insightful report titled Japan In-Vitro Diagnostics (IVD) Market, Size, Forecast 2023-2028, Industry Trends, Growth, Share, Outlook, Impact of Inflation, Opportunity Company Analysis, which details the current landscape and future trends in the IVD industry in Japan. The report highlights that the market is expected to experience a compound annual growth rate (CAGR) of 3.53% from 2022 to 2028.
The demand for molecular diagnostic tests is increasing due to the rise in chronic diseases and the growing need for personalized medicine. Furthermore, advancements in automation and digital technologies are anticipated to enhance the speed and accuracy of testing processes. The focus on preventive healthcare and early disease detection is driving the development of innovative screening tests.
Evolving Regulatory Landscape
The regulatory environment for IVD products in Japan is also evolving. The Pharmaceuticals and Medical Devices Agency (PMDA) has introduced new guidelines to simplify the approval process for IVD products, making it easier and more cost-effective for new technologies to enter the market.
Aging Population and Increased Demand for IVD Tests
Japan’s demographic landscape is shifting, with approximately 28% of its population aged 65 or older. This aging population is more susceptible to chronic diseases such as cancer, diabetes, and cardiovascular diseases, creating a heightened demand for IVD tests that aid in early detection and management of these conditions. Japan’s advanced healthcare system is well-equipped to meet this demand, with some of the world’s leading medical technology companies at the forefront of IVD innovation.
Growth of Genetic Testing in Japan
Genetic testing is becoming increasingly significant in Japan’s IVD market. With an aging population, the demand for tests that detect genetic variations is on the rise, as they play a crucial role in personalized medicine. For instance, genetic tests can help tailor treatment plans based on a patient’s genetic profile, enabling more targeted interventions. Additionally, the rise of non-invasive prenatal testing (NIPT) is contributing to the growth of genetic testing in Japan.
Competitive Landscape
The competitive environment in Japan’s IVD market features several key players, including:
- Roche Diagnostics
- Abbott Laboratories
- Biomerieux
- Danaher Corporation
- Becton
- Bio-Rad Laboratories, Inc.
- Sysmex Corporation
- Thermo Fisher Scientific Inc.
These companies are competing to develop and market advanced IVD tests and devices, particularly in response to the growing demand stemming from the elderly population and the prevalence of chronic diseases.
Related Reports
Conclusion
The Japan In-Vitro Diagnostics (IVD) market is poised for substantial growth, driven by factors such as an aging population, increasing chronic disease prevalence, and advancements in technology and regulatory processes. The emphasis on genetic testing and personalized medicine further underscores the market’s potential, making it a vital area for investment and development.
About Renub Research
Renub Research is a market research and information analysis company with over 14 years of experience. We provide comprehensive insights to assist companies in strategic decision-making across various industries. With over 7000 syndicated reports and 500 custom research projects, our data supports major organizations such as EMIS, Bloomberg, and Thomson Reuters.
For more information, visit our website: www.renub.com.
Media Contact:
Company Name: Renub Research
Contact Person: Rajat Gupta, Marketing Manager
Phone No: +1-478-202-3244 | +91-120-421-9822 (IND)
Email: info@renub.com
LinkedIn: Renub Research
